AstraZeneca Aktie
120,55
EUR
+0,05
EUR
+0,04
%
1.344,50
SEK
+26,00
SEK
+1,97
%
Werbung
AstraZeneca Aktie Analyse
14.09.16 | AstraZeneca Neutral | BNP PARIBAS | |
06.09.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
11.08.16 | AstraZeneca Hold | HSBC | |
10.08.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
09.08.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
08.08.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
08.08.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
04.08.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
Werbung
|
|||
02.08.16 | AstraZeneca Hold | HSBC | |
29.07.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
29.07.16 | AstraZeneca neutral | Bernstein Research | |
21.07.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
14.07.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
13.07.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
30.06.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
14.06.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
07.06.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
19.05.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
11.05.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
09.05.16 | AstraZeneca neutral | Independent Research GmbH | |
04.05.16 | AstraZeneca Hold | HSBC | |
03.05.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
26.04.16 | AstraZeneca neutral | Bernstein Research | |
21.04.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
15.04.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
11.04.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
31.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
24.03.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
22.03.16 | AstraZeneca Hold | HSBC | |
15.03.16 | AstraZeneca Hold | Jefferies & Company Inc. | |
01.03.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
19.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
08.02.16 | AstraZeneca Halten | Independent Research GmbH | |
08.02.16 | AstraZeneca Hold | HSBC | |
05.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
05.02.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
04.02.16 | AstraZeneca Hold | S&P Capital IQ | |
01.02.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
19.01.16 | AstraZeneca Equal weight | Barclays Capital | |
18.01.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
07.01.16 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
05.01.16 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
18.12.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
25.11.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
18.11.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
13.11.15 | AstraZeneca Halten | Independent Research GmbH | |
09.11.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
28.10.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
27.10.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
21.10.15 | AstraZeneca market-perform | Bernstein Research |
Werbung
Werbung